Business / Finance

RSS

HUOH pays $3,500,000 in dividends to Ohio doctor owners/insureds in the last 40 months

HUOH is committed to its policyholders and their professional reputation by having a "zero tolerance" for nuisance claims and unparalleled aggressive defense programs for its physicians. Once again, continuing to build on its success from 2010, HUOH is attracting extraordinary physicians, managing claims exceptionally and now delivering another dividend to its' Ohio physician owners of $1,000,000.

8 Nov 2011

Medidata third quarter revenues increase 13% to $46.3 million

Medidata Solutions, a leading global provider of SaaS-based clinical technology solutions that enhance the efficiency of clinical development, today announced its financial results for the third quarter 2011, as well as provided financial guidance for the fourth quarter and full year 2011.

8 Nov 2011

CHS commences cash tender offer for 8⅞% Senior Notes due 2015

Community Health Systems, Inc. today announced that its wholly-owned subsidiary, CHS/Community Health Systems, Inc., has commenced a cash tender offer for up to $1.0 billion of the Issuer's approximately $2.8 billion aggregate principal amount outstanding of its 8⅞% Senior Notes due 2015 on the terms and subject to the conditions set forth in the Issuer's Offer to Purchase dated November 7, 2011.

8 Nov 2011

EpiCept reports net loss of $5.4 million for third quarter 2011

EpiCept Corporation today announced operating and financial results for the three and nine months ended September 30, 2011, and provided an update with respect to the Company's key business initiatives.

8 Nov 2011

Quintiles closes agreement to acquire Advion BioServices

Quintiles' ability to provide customers with actionable early-stage data to make better development decisions faster has taken a significant step forward with the closing of the previously announced agreement to acquire Advion BioServices, a premier U.S.-based bioanalytical laboratory.

From Advion 7 Nov 2011

Amgen plans $5 billion auction tender offer

Amgen today announced its plan to launch a modified Dutch auction tender offer to purchase up to $5 billion of its common stock, par value $0.0001 per share.

7 Nov 2011

Perrigo and Synthon commence shipping generic Xyzal Oral Solution

Perrigo Company and its partner Synthon Pharmaceuticals, Inc. today announced that Perrigo has begun shipping Levocetirizine Solution, 2.5 mg/5ml, a generic version of UCB's Xyzal Oral Solution.

7 Nov 2011

Cubist announces commencement of tender offer for all outstanding shares of Adolor common stock

Cubist Pharmaceuticals, Inc. today announced the commencement of its tender offer for all outstanding shares of the common stock of Adolor Corporation for $4.25 per share in cash, plus one nontransferable Contingent Payment Right entitling the holder to receive additional cash payments of up to $4.50 for each share tendered if certain regulatory approvals and/or commercialization milestones for ADL5945 are achieved.

7 Nov 2011

SurgLine to deliver first surgical instrumentation products to Denver hospital system

China Nuvo Solar Energy, Inc. today announced that its wholly owned subsidiary, SurgLine will deliver its first surgical instrumentation products to one of Denver's largest acute care hospital systems for use by one of its outpatient surgery centers.

7 Nov 2011

Prostate cancer drug market forecast to grow from $3.6 billion in 2010 to $10.1 billion in 2020

Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that, driven by the launches of several promising emerging therapies, the prostate cancer drug market will experience robust growth over the next decade, increasing from $3.6 billion in 2010 to $10.1 billion in 2020 in the United States, France, Germany, Italy, Spain, the United Kingdom and Japan.

7 Nov 2011

NanoString closes $20M Series D round of equity financing

NanoString Technologies, Inc., a privately held provider of life science tools for translational research and developer of molecular diagnostics, today announced that it has closed $20 million in a Series D round of equity financing.

From NanoString Technologies 7 Nov 2011

A.P. Pharma's third quarter net loss increases to $4.2 million

A.P. Pharma, Inc., a specialty pharmaceutical company, today reported financial results for its third quarter ended September 30, 2011 and highlighted its recent corporate progress.

7 Nov 2011

Zimmer commences $550M public offering of senior notes

Zimmer Holdings, Inc. announced today that it has commenced a $550 million public offering of senior notes.

7 Nov 2011

Transgenomic and A. Menarini Diagnostics enter distribution agreement for mutation detection systems

Transgenomic, Inc. and A. Menarini Diagnostics today announced an exclusive distribution agreement for Transgenomic's SURVEYOR Scan and WAVE MCE (Micro-Capillary Electrophoresis) Mutation Detection system to its network of over 2,000 pathologists throughout Europe.

7 Nov 2011

Pharmacyclics first quarter GAAP net loss increases to $14.5M

Pharmacyclics, Inc. today reported financial results and recent developments for its fiscal first quarter ended September 30, 2011.

7 Nov 2011

American Access Care sold to to Fresenius Medical Care

TA Associates, a leading global growth private equity firm, today announced the sale of its portfolio company American Access Care (AAC) to Fresenius Medical Care AG & Co. KGaA.

7 Nov 2011

Thoratec board authorizes repurchase of additional $50M of common stock

Thoratec Corporation, a world leader in device-based mechanical circulatory support therapies to save, support and restore failing hearts, announced today that its Board of Directors has authorized the repurchase of an additional $50 million of the company's shares of common stock over the next year.

7 Nov 2011

Chemed board authorizes additional $100M stock repurchase program

Chemed Corporation announced today that the Board of Directors has formally authorized an additional $100 million for stock repurchase under Chemed's existing share repurchase program. These share repurchases will be funded through a combination of cash generated from operations as well as utilization of its revolving credit facility.

7 Nov 2011

Transcend third quarter revenue increases 41% to $32,202,000

TRANSCEND SERVICES, INC., a leading provider of clinical documentation solutions to the U.S. healthcare market, today announced its unaudited financial results for the third quarter ended September 30, 2011.

7 Nov 2011

Getinge receives FTC approval to acquire Atrium Medical

Getinge has been granted the approval of US anti-trust authority FTC (Federal Trade Commission) to go ahead with the acquisition of Atrium Medical Inc. The acquisition was finalized on 4 November, 2011, and will be consolidated in Getinge's accounts as of 1 November this year.

7 Nov 2011